Literature DB >> 29904179

Utility of two SMN1 variants to improve spinal muscular atrophy carrier diagnosis and genetic counselling.

Laura Alías1,2, Sara Bernal1, Maite Calucho3, Elisabeth Martínez1, Francesca March1, Pia Gallano1,2, Pablo Fuentes-Prior4, Anna Abuli3,5, Clara Serra-Juhe3,5, Eduardo F Tizzano6,7,8.   

Abstract

Spinal muscular atrophy (SMA) is caused by deletions/mutations in SMN1. Most heterozygous SMA carriers have only one SMN1 copy in one of the alleles (1/0 carriers). However, a few carriers lack SMN1 in one of their chromosomes, but present two gene copies in the other. These "2/0 carriers" are undistinguishable from non-carrier individuals (1/1) with currently available methods. Previous association of SMN1 variants c.*3 + 80 T > G and c.*211_*212del with two SMN1 copies in cis in Ashkenazi population prompted us to analyze them in 270 Spanish individuals (SMA carriers, patients and general population). Both variants were much more frequently detected in chromosomes with 2 SMN1 copies in cis in comparison with chromosomes carrying one copy (17.9 vs. 0.7%; p < 0.001). In particular, one-fifth of 2/0 SMA carriers harboured one or both variants compared to none of 99 non-carriers with two SMN1 copies (p < 0.001). The c.*211_*212del variant was also much more frequent in exon 8 of SMN2-SMN1 hybrids than in that of intact SMN1 genes (20 vs. 0.83%, p < 0.001), suggesting its association with chromosomal rearrangements. Although absence of these variants does not exclude that a particular individual is a 2/0 SMA carrier, their presence is valuable to substantially increase residual risk in putative carriers, thus improving genetic counselling.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29904179      PMCID: PMC6138687          DOI: 10.1038/s41431-018-0193-4

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  16 in total

1.  Nomenclature for the description of human sequence variations.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

2.  Characterisation of SMN hybrid genes in Spanish SMA patients: de novo, homozygous and compound heterozygous cases.

Authors:  I Cuscó; M J Barceló; E del Rio; Y Martín; C Hernández-Chico; E Bussaglia; M Baiget; E F Tizzano
Journal:  Hum Genet       Date:  2001-03       Impact factor: 4.132

Review 3.  An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).

Authors:  B Wirth
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

4.  Accuracy of marker analysis, quantitative real-time polymerase chain reaction, and multiple ligation-dependent probe amplification to determine SMN2 copy number in patients with spinal muscular atrophy.

Authors:  Laura Alías; Sara Bernal; Maria J Barceló; Eva Also-Rallo; Rebeca Martínez-Hernández; Francisco J Rodríguez-Alvarez; Concepción Hernández-Chico; Montserrat Baiget; Eduardo F Tizzano
Journal:  Genet Test Mol Biomarkers       Date:  2011-05-06

5.  Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene.

Authors:  Laura Alías; Sara Bernal; Pablo Fuentes-Prior; María Jesus Barceló; Eva Also; Rebeca Martínez-Hernández; Francisco J Rodríguez-Alvarez; Yolanda Martín; Elena Aller; Elena Grau; Ana Peciña; Guillermo Antiñolo; Enrique Galán; Alberto L Rosa; Miguel Fernández-Burriel; Salud Borrego; José M Millán; Concepción Hernández-Chico; Montserrat Baiget; Eduardo F Tizzano
Journal:  Hum Genet       Date:  2008-12-03       Impact factor: 4.132

6.  Structure and organization of the human survival motor neurone (SMN) gene.

Authors:  L Bürglen; S Lefebvre; O Clermont; P Burlet; L Viollet; C Cruaud; A Munnich; J Melki
Journal:  Genomics       Date:  1996-03-15       Impact factor: 5.736

7.  Two independent mutations of the SMN1 gene in the same spinal muscular atrophy family branch: lessons for carrier diagnosis.

Authors:  María Jesús Barceló; Laura Alias; Lídia Caselles; Yolanda Robles; Montserrat Baiget; Eduardo F Tizzano
Journal:  Genet Med       Date:  2006-04       Impact factor: 8.822

Review 8.  The clinical landscape for SMA in a new therapeutic era.

Authors:  K Talbot; E F Tizzano
Journal:  Gene Ther       Date:  2017-07-23       Impact factor: 5.250

9.  Differences in SMN1 allele frequencies among ethnic groups within North America.

Authors:  B C Hendrickson; C Donohoe; V R Akmaev; E A Sugarman; P Labrousse; L Boguslavskiy; K Flynn; E M Rohlfs; A Walker; B Allitto; C Sears; T Scholl
Journal:  J Med Genet       Date:  2009-07-21       Impact factor: 6.318

10.  An Ashkenazi Jewish SMN1 haplotype specific to duplication alleles improves pan-ethnic carrier screening for spinal muscular atrophy.

Authors:  Minjie Luo; Liu Liu; Inga Peter; Jun Zhu; Stuart A Scott; Geping Zhao; Chevonne Eversley; Ruth Kornreich; Robert J Desnick; Lisa Edelmann
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

View more
  8 in total

1.  Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR.

Authors:  Deborah L Stabley; Jennifer Holbrook; Mena Scavina; Thomas O Crawford; Kathryn J Swoboda; Katherine M Robbins; Matthew E R Butchbach
Journal:  Neurogenetics       Date:  2021-01-07       Impact factor: 2.660

2.  SMN1 gene copy number analysis for spinal muscular atrophy (SMA) in a Turkish cohort by CODE-SEQ technology, an integrated solution for detection of SMN1 and SMN2 copy numbers and the "2+0" genotype.

Authors:  Ahmet Cevdet Ceylan; Haktan Bağış Erdem; İbrahim Şahin; Meenal Agarwal
Journal:  Neurol Sci       Date:  2020-04-06       Impact factor: 3.307

3.  Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots.

Authors:  Yogik Onky Silvana Wijaya; Jamiyan Purevsuren; Nur Imma Fatimah Harahap; Emma Tabe Eko Niba; Yoshihiro Bouike; Dian Kesumapramudya Nurputra; Mawaddah Ar Rochmah; Cempaka Thursina; Sunartini Hapsara; Seiji Yamaguchi; Hisahide Nishio; Masakazu Shinohara
Journal:  Int J Neonatal Screen       Date:  2020-05-29

4.  The clinical utility of a risk-modifying SNP to detect carriers for spinal muscular atrophy with increased sensitivity.

Authors:  Gardenier Ware; Cecelia Miller; Dan Jones; Matthew Avenarius
Journal:  Mol Genet Genomic Med       Date:  2022-03-15       Impact factor: 2.183

Review 5.  Recommendations for Interpreting and Reporting Silent Carrier and Disease-Modifying Variants in SMA Testing Workflows.

Authors:  John N Milligan; Laura Blasco-Pérez; Mar Costa-Roger; Marta Codina-Solà; Eduardo F Tizzano
Journal:  Genes (Basel)       Date:  2022-09-15       Impact factor: 4.141

6.  Multisite Evaluation and Validation of a Sensitive Diagnostic and Screening System for Spinal Muscular Atrophy that Reports SMN1 and SMN2 Copy Number, along with Disease Modifier and Gene Duplication Variants.

Authors:  John N Milligan; Jessica L Larson; Stela Filipovic-Sadic; Walairat Laosinchai-Wolf; Ya-Wen Huang; Tsang-Ming Ko; Kristin M Abbott; Henny H Lemmink; Minna Toivonen; Johanna Schleutker; Caren Gentile; Vivianna M Van Deerlin; Huiping Zhu; Gary J Latham
Journal:  J Mol Diagn       Date:  2021-03-30       Impact factor: 5.341

7.  SMN1 copy-number and sequence variant analysis from next-generation sequencing data.

Authors:  Daniel Lopez-Lopez; Carlos Loucera; Rosario Carmona; Virginia Aquino; Josefa Salgado; Sara Pasalodos; María Miranda; Ángel Alonso; Joaquín Dopazo
Journal:  Hum Mutat       Date:  2020-10-14       Impact factor: 4.878

Review 8.  Cytogenetic and molecular diagnostic testing associated with prenatal and postnatal birth defects.

Authors:  Stela Z Berisha; Shashi Shetty; Thomas W Prior; Anna L Mitchell
Journal:  Birth Defects Res       Date:  2020-03-01       Impact factor: 2.661

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.